Company / Operating Cash Flow per Share
CRESCENT BIOPHARMA, INC. Operating Cash Flow per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$70.23
FY2025
5-year range
-$70.23 / -$0.22
FY2021-FY2025
Trend
-19710.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Cash Flow per Share changed -19710% YoY in FY2025, a notable deviation from the 4-year average annual change of -4902%.
Based on SEC 10-K filings.
-70.23 in FY2025.
Declined from $-0.22 to $-70.23 over the past 9 years.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating cash flow per share decreased 19710.3% year-over-year.
- Peak operating cash flow per share was recorded in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$70.23 | -19710.3% |
| FY2017 | -$0.35 | -57.7% |
| FY2016 | -$0.22 | +72.6% |
| FY2015 | -$0.82 | +88.8% |
| FY2014 | -$7.34 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026